$PTGX
-
Markets
Protagonist Therapeutics Unveils Groundbreaking Results For Icotrokinra In Plaque Psoriasis Treatment
$PTGX Protagonist Therapeutics (NASDAQ: PTGX) has announced promising results from its Phase 3 clinical trials for icotrokinra, an oral treatment…
Read More » -
Markets
Protagonist Therapeutics Achieves Remarkable Financial Growth And Clinical Advancements
$PTGX Protagonist Therapeutics (NASDAQ:PTGX), known for its innovative peptide-based drugs, has seen a notable increase in its financial metrics and…
Read More »